A 0 1 0 1 O
prolonged 2 11 2 11 O
history 12 19 12 19 O
of 20 22 20 22 O
cigarette 23 32 23 32 O
smoking 33 40 33 40 O
( 41 42 41 42 O
20 42 44 42 44 B-upper_bound
pk 45 47 45 47 I-upper_bound
/ 47 48 47 48 I-upper_bound
year 48 52 48 52 I-upper_bound
of 53 55 53 55 O
smoking 56 63 56 63 O
within 64 70 64 70 O
the 71 74 71 74 O
past 75 79 75 79 B-upper_bound
2 80 81 80 81 I-upper_bound
years 82 87 82 87 I-upper_bound
) 87 88 87 88 O

Absolute 0 8 89 97 B-clinical_variable
neutrophil 9 19 98 108 I-clinical_variable
count 20 25 109 114 I-clinical_variable
greater 26 33 115 122 O
than 34 38 123 127 O
1000 39 43 128 132 B-lower_bound
/ 43 44 132 133 I-lower_bound
mm^3 44 48 133 137 I-lower_bound
without 49 56 138 145 O
the 57 60 146 149 O
support 61 68 150 157 O
of 69 71 158 160 O
filgrastim 72 82 161 171 B-treatment

Active 0 6 172 178 O
systemic 7 15 179 187 B-chronic_disease
infections 16 26 188 198 I-chronic_disease
, 26 27 198 199 O
( 28 29 200 201 O
e.g. 29 33 201 205 O
: 33 34 205 206 O
requiring 35 44 207 216 O
anti 45 49 217 221 B-treatment
- 49 50 221 222 I-treatment
infective 50 59 222 231 I-treatment
treatment 60 69 232 241 I-treatment
) 69 70 241 242 O
, 70 71 242 243 O
coagulation 72 83 244 255 B-chronic_disease
disorders 84 93 256 265 I-chronic_disease
or 94 96 266 268 O
any 97 100 269 272 O
other 101 106 273 278 O
active 107 113 279 285 O
major 114 119 286 291 O
medical 120 127 292 299 O
illnesses 128 137 300 309 O

Any 0 3 310 313 O
form 4 8 314 318 O
of 9 11 319 321 O
primary 12 19 322 329 B-chronic_disease
immunodeficiency 20 36 330 346 I-chronic_disease
( 37 38 347 348 O
such 38 42 348 352 O
as 43 45 353 355 O
Severe 46 52 356 362 B-chronic_disease
Combined 53 61 363 371 I-chronic_disease
Immunodeficiency 62 78 372 388 I-chronic_disease
Disease 79 86 389 396 I-chronic_disease
) 86 87 396 397 O

Clinical 0 8 398 406 B-clinical_variable
performance 9 20 407 418 I-clinical_variable
status 21 27 419 425 I-clinical_variable
of 28 30 426 428 O
ECOG 31 35 429 433 B-clinical_variable
0 36 37 434 435 B-lower_bound
or 38 40 436 438 O
1 41 42 439 440 B-upper_bound

Clinically 0 10 441 451 O
significant 11 22 452 463 O
atrial 23 29 464 470 B-chronic_disease
and 30 33 471 474 O
or 34 36 475 477 O
ventricular 37 48 478 489 B-chronic_disease
arrhythmias 49 60 490 501 I-chronic_disease
including 61 70 502 511 O
but 71 74 512 515 O
not 75 78 516 519 O
limited 79 86 520 527 O
to 87 89 528 530 O
: 89 90 530 531 O
atrial 91 97 532 538 B-chronic_disease
fibrillation 98 110 539 551 I-chronic_disease
, 110 111 551 552 O
ventricular 112 123 553 564 B-chronic_disease
tachycardia 124 135 565 576 I-chronic_disease
, 135 136 576 577 O
second 137 143 578 584 O
or 144 146 585 587 O
third 147 152 588 593 O
degree 153 159 594 600 O
heart 160 165 601 606 B-chronic_disease
block 166 171 607 612 I-chronic_disease
or 172 174 613 615 O
have 175 179 616 620 O
a 180 181 621 622 O
history 182 189 623 630 O
of 190 192 631 633 O
ischemic 193 201 634 642 B-chronic_disease
heart 202 207 643 648 I-chronic_disease
disease 208 215 649 656 I-chronic_disease
, 215 216 656 657 O
or 217 219 658 660 O
chest 220 225 661 666 O
pain 226 230 667 671 O

Concurrent 0 10 672 682 B-chronic_disease
opportunistic 11 24 683 696 I-chronic_disease
infections 25 35 697 707 I-chronic_disease
( 36 37 708 709 O
The 37 40 709 712 O
experimental 41 53 713 725 B-treatment
treatment 54 63 726 735 I-treatment
being 64 69 736 741 O
evaluated 70 79 742 751 O
in 80 82 752 754 O
this 83 87 755 759 O
protocol 88 96 760 768 O
depends 97 104 769 776 O
on 105 107 777 779 O
an 108 110 780 782 O
intact 111 117 783 789 O
immune 118 124 790 796 O
system 125 131 797 803 O
. 131 132 803 804 O
Patients 133 141 805 813 O
who 142 145 814 817 O
have 146 150 818 822 O
decreased 151 160 823 832 O
immune 161 167 833 839 O
competence 168 178 840 850 O
may 179 182 851 854 O
be 183 185 855 857 O
less 186 190 858 862 O
responsive 191 201 863 873 O
to 202 204 874 876 O
the 205 208 877 880 O
experimental 209 221 881 893 O
treatment 222 231 894 903 O
and 232 235 904 907 O
more 236 240 908 912 O
susceptible 241 252 913 924 O
to 253 255 925 927 O
its 256 259 928 931 O
toxicities 260 270 932 942 O
) 270 271 942 943 O

Concurrent 0 10 944 954 B-treatment
systemic 11 19 955 963 I-treatment
steroid 20 27 964 971 I-treatment
therapy 28 35 972 979 I-treatment

Documented 0 10 980 990 O
FEV1 11 15 991 995 B-clinical_variable
less 16 20 996 1000 O
than 21 25 1001 1005 O
or 26 28 1006 1008 O
equal 29 34 1009 1014 O
to 35 37 1015 1017 O
60 38 40 1018 1020 B-upper_bound
% 40 41 1020 1021 I-upper_bound
predicted 42 51 1022 1031 O
tested 52 58 1032 1038 O
in 59 61 1039 1041 O
patients 62 70 1042 1050 O
with 71 75 1051 1055 O

Documented 0 10 1056 1066 O
LVEF 11 15 1067 1071 B-clinical_variable
of 16 18 1072 1074 O
less 19 23 1075 1079 O
than 24 28 1080 1084 O
or 29 31 1085 1087 O
equal 32 37 1088 1093 O
to 38 40 1094 1096 O
45 41 43 1097 1099 B-upper_bound
% 43 44 1099 1100 I-upper_bound
testing 45 52 1101 1108 O
is 53 55 1109 1111 O
required 56 64 1112 1120 O
in 65 67 1121 1123 O
patients 68 76 1124 1132 O
who 77 80 1133 1136 O
are 81 84 1137 1140 O

Greater 0 7 1141 1148 O
than 8 12 1149 1153 O
or 13 15 1154 1156 O
equal 16 21 1157 1162 O
to 22 24 1163 1165 O
18 25 27 1166 1168 B-lower_bound
years 28 33 1169 1174 I-lower_bound
of 34 36 1175 1177 O
age 37 40 1178 1181 B-age
and 41 44 1182 1185 O
less 45 49 1186 1190 O
than 50 54 1191 1195 O
or 55 57 1196 1198 O
equal 58 63 1199 1204 O
to 64 66 1205 1207 O
age 67 70 1208 1211 O

History 0 7 1212 1219 O
of 8 10 1220 1222 O
any 11 14 1223 1226 O
cardiac 15 22 1227 1234 B-chronic_disease
events 23 29 1235 1241 I-chronic_disease
including 30 39 1242 1251 O
coronary 40 48 1252 1260 B-treatment
revascularization 49 66 1261 1278 I-treatment
or 67 69 1279 1281 O
ischemic 70 78 1282 1290 O
symptoms 79 87 1291 1299 O

History 0 7 1300 1307 O
of 8 10 1308 1310 O
severe 11 17 1311 1317 O
immediate 18 27 1318 1327 O
hypersensitivity 28 44 1328 1344 O
reaction 45 53 1345 1353 O
to 54 56 1354 1356 O
any 57 60 1357 1360 B-allergy_name
of 61 63 1361 1363 I-allergy_name
the 64 67 1364 1367 I-allergy_name
agents 68 74 1368 1374 I-allergy_name
used 75 79 1375 1379 I-allergy_name
in 80 82 1380 1382 I-allergy_name
this 83 87 1383 1387 I-allergy_name
study 88 93 1388 1393 I-allergy_name

If 0 2 1394 1396 O
hepatitis 3 12 1397 1406 B-treatment
C 13 14 1407 1408 I-treatment
antibody 15 23 1409 1417 I-treatment
test 24 28 1418 1422 O
is 29 31 1423 1425 O
positive 32 40 1426 1434 O
, 40 41 1434 1435 O
then 42 46 1436 1440 O
patient 47 54 1441 1448 O
must 55 59 1449 1453 O
be 60 62 1454 1456 O
tested 63 69 1457 1463 O
for 70 73 1464 1467 O
the 74 77 1468 1471 O
presence 78 86 1472 1480 O
of 87 89 1481 1483 O
antigen 90 97 1484 1491 O
by 98 100 1492 1494 O
RT 101 103 1495 1497 O
- 103 104 1497 1498 O
PCR 104 107 1498 1501 O
and 108 111 1502 1505 O
be 112 114 1506 1508 O
HCV 115 118 1509 1512 B-treatment
RNA 119 122 1513 1516 I-treatment
negative 123 131 1517 1525 O

Lesions 0 7 1526 1533 O
that 8 12 1534 1538 O
have 13 17 1539 1543 O
been 18 22 1544 1548 O
treated 23 30 1549 1556 O
with 31 35 1557 1561 O
stereotactic 36 48 1562 1574 B-treatment
radiosurgery 49 61 1575 1587 I-treatment
must 62 66 1588 1592 O
be 67 69 1593 1595 O
clinically 70 80 1596 1606 O
stable 81 87 1607 1613 O
for 88 91 1614 1617 O
1 92 93 1618 1619 B-upper_bound
month 94 99 1620 1625 I-upper_bound
after 100 105 1626 1631 I-upper_bound
treatment 106 115 1632 1641 B-treatment
for 116 119 1642 1645 O
the 120 123 1646 1649 O
patient 124 131 1650 1657 O
to 132 134 1658 1660 O
be 135 137 1661 1663 O
eligible 138 146 1664 1672 O
. 146 147 1672 1673 O
Patients 148 156 1674 1682 O
with 157 161 1683 1687 O
surgically 162 172 1688 1698 O
resected 173 181 1699 1707 O
brain 182 187 1708 1713 B-cancer
metastases 188 198 1714 1724 I-cancer
are 199 202 1725 1728 O
eligible 203 211 1729 1737 O

Metastatic 0 10 1738 1748 B-cancer
cancer 11 17 1749 1755 I-cancer
diagnosis 18 27 1756 1765 O
will 28 32 1766 1770 O
be 33 35 1771 1773 O
confirmed 36 45 1774 1783 O
by 46 48 1784 1786 O
the 49 52 1787 1790 O
Laboratory 53 63 1791 1801 O
of 64 66 1802 1804 O
Pathology 67 76 1805 1814 O
at 77 79 1815 1817 O
the 80 83 1818 1821 O
NCI 84 87 1822 1825 O

Metastatic 0 10 1826 1836 B-cancer
or 11 13 1837 1839 I-cancer
locally 14 21 1840 1847 I-cancer
advanced 22 30 1848 1856 I-cancer
refractory 31 41 1857 1867 I-cancer
/ 41 42 1867 1868 O
recurrent 42 51 1868 1877 O
cancer 52 58 1878 1884 B-cancer
that 59 63 1885 1889 O
expresses 64 73 1890 1899 O
MAGE 74 78 1900 1904 O
- 78 79 1904 1905 O
A3 79 81 1905 1907 O
as 82 84 1908 1910 O
assessed 85 93 1911 1919 O
by 94 96 1920 1922 O
one 97 100 1923 1926 O
of 101 103 1927 1929 O
the 104 107 1930 1933 O
following 108 117 1934 1943 O
methods 118 125 1944 1951 O
: 125 126 1951 1952 O
RT 127 129 1953 1955 O
- 129 130 1955 1956 O
PCR 130 133 1956 1959 O
on 134 136 1960 1962 O
tumor 137 142 1963 1968 B-cancer
tissue 143 149 1969 1975 O
defined 150 157 1976 1983 O
as 158 160 1984 1986 O
30,000 161 167 1987 1993 O
copies 168 174 1994 2000 O
of 175 177 2001 2003 O
MAGE 178 182 2004 2008 O
- 182 183 2008 2009 O
A3 183 185 2009 2011 O
per 186 189 2012 2015 O
10 190 192 2016 2018 O
^ 192 193 2018 2019 O
6 193 194 2019 2020 O
GAPDH 195 200 2021 2026 O
copies 201 207 2027 2033 O

More 0 4 2034 2038 O
than 5 9 2039 2043 O
four 10 14 2044 2048 B-lower_bound
weeks 15 20 2049 2054 I-lower_bound
must 21 25 2055 2059 O
have 26 30 2060 2064 O
elapsed 31 38 2065 2072 O
since 39 44 2073 2078 O
any 45 48 2079 2082 O
prior 49 54 2083 2088 B-treatment
systemic 55 63 2089 2097 I-treatment
therapy 64 71 2098 2105 I-treatment
at 72 74 2106 2108 O
the 75 78 2109 2112 O
time 79 83 2113 2117 O
the 84 87 2118 2121 O
patient 88 95 2122 2129 O
receives 96 104 2130 2138 O
the 105 108 2139 2142 O
preparative 109 120 2143 2154 B-treatment
regimen 121 128 2155 2162 I-treatment
, 128 129 2162 2163 O
and 130 133 2164 2167 O
patients 134 142 2168 2176 O
' 142 143 2176 2177 O
toxicities 144 154 2178 2188 O
must 155 159 2189 2193 O
have 160 164 2194 2198 O
recovered 165 174 2199 2208 O
to 175 177 2209 2211 O
a 178 179 2212 2213 O
grade 180 185 2214 2219 B-upper_bound
1 186 187 2220 2221 I-upper_bound
or 188 190 2222 2224 O
less 191 195 2225 2229 O
( 196 197 2230 2231 O
except 197 203 2231 2237 O
for 204 207 2238 2241 O
toxicities 208 218 2242 2252 O
such 219 223 2253 2257 O
as 224 226 2258 2260 O
alopecia 227 235 2261 2269 B-chronic_disease
or 236 238 2270 2272 O
vitiligo 239 247 2273 2281 B-chronic_disease
) 247 248 2281 2282 O

Patients 0 8 2283 2291 O
must 9 13 2292 2296 O
be 14 16 2297 2299 O
HLA 17 20 2300 2303 B-clinical_variable
- 20 21 2303 2304 I-clinical_variable
DP4 21 24 2304 2307 I-clinical_variable
positive 25 33 2308 2316 O

Patients 0 8 2317 2325 O
must 9 13 2326 2330 O
have 14 18 2331 2335 O
previously 19 29 2336 2346 O
received 30 38 2347 2355 O
prior 39 44 2356 2361 B-treatment
first 45 50 2362 2367 I-treatment
line 51 55 2368 2372 I-treatment
standard 56 64 2373 2381 I-treatment
therapy 65 72 2382 2389 I-treatment
( 73 74 2390 2391 O
or 74 76 2391 2393 O
effective 77 86 2394 2403 O
salvage 87 94 2404 2411 B-treatment
chemotherapy 95 107 2412 2424 I-treatment
regimens 108 116 2425 2433 I-treatment
) 116 117 2433 2434 O
for 118 121 2435 2438 O
their 122 127 2439 2444 O
disease 128 135 2445 2452 O
, 135 136 2452 2453 O
if 137 139 2454 2456 O
known 140 145 2457 2462 O
to 146 148 2463 2465 O
be 149 151 2466 2468 O
effective 152 161 2469 2478 O
for 162 165 2479 2482 O
that 166 170 2483 2487 O
disease 171 178 2488 2495 O
, 178 179 2495 2496 O
and 180 183 2497 2500 O
have 184 188 2501 2505 O
been 189 193 2506 2510 O
either 194 200 2511 2517 O
non 201 204 2518 2521 O
- 204 205 2521 2522 O
responders 205 215 2522 2532 O
( 216 217 2533 2534 O
progressive 217 228 2534 2545 O
disease 229 236 2546 2553 O
) 236 237 2553 2554 O
or 238 240 2555 2557 O
have 241 245 2558 2562 O
recurred 246 254 2563 2571 O

Patients 0 8 2572 2580 O
of 9 11 2581 2583 O
both 12 16 2584 2588 O
genders 17 24 2589 2596 O
must 25 29 2597 2601 O
be 30 32 2602 2604 O
willing 33 40 2605 2612 B-contraception_consent
to 41 43 2613 2615 I-contraception_consent
practice 44 52 2616 2624 I-contraception_consent
birth 53 58 2625 2630 I-contraception_consent
control 59 66 2631 2638 I-contraception_consent
from 67 71 2639 2643 O
the 72 75 2644 2647 O
time 76 80 2648 2652 O
of 81 83 2653 2655 O
enrollment 84 94 2656 2666 O
on 95 97 2667 2669 O
this 98 102 2670 2674 O
study 103 108 2675 2680 O
and 109 112 2681 2684 O
for 113 116 2685 2688 O
up 117 119 2689 2691 O
to 120 122 2692 2694 O
four 123 127 2695 2699 B-upper_bound
months 128 134 2700 2706 I-upper_bound
after 135 140 2707 2712 O
treatment 141 150 2713 2722 B-treatment

Patients 0 8 2723 2731 O
who 9 12 2732 2735 O
are 13 16 2736 2739 O
receiving 17 26 2740 2749 O
any 27 30 2750 2753 O
other 31 36 2754 2759 O
investigational 37 52 2760 2775 B-treatment
agents 53 59 2776 2782 I-treatment

Patients 0 8 2783 2791 O
who 9 12 2792 2795 O
have 13 17 2796 2800 O
previously 18 28 2801 2811 O
received 29 37 2812 2820 O
ipilimumab 38 48 2821 2831 B-treatment
and 49 52 2832 2835 O
have 53 57 2836 2840 O
documented 58 68 2841 2851 O
GI 69 71 2852 2854 B-chronic_disease
toxicity 72 80 2855 2863 I-chronic_disease
must 81 85 2864 2868 O
have 86 90 2869 2873 O
a 91 92 2874 2875 O
normal 93 99 2876 2882 O
colonoscopy 100 111 2883 2894 B-treatment
with 112 116 2895 2899 O
normal 117 123 2900 2906 O
colonic 124 131 2907 2914 B-treatment
biopsies 132 140 2915 2923 I-treatment

Patients 0 8 2924 2932 O
with 9 13 2933 2937 O
3 14 15 2938 2939 B-upper_bound
or 16 18 2940 2942 O
fewer 19 24 2943 2948 O
brain 25 30 2949 2954 B-clinical_variable
metastases 31 41 2955 2965 I-clinical_variable
that 42 46 2966 2970 O
are 47 50 2971 2974 O
less 51 55 2975 2979 O
than 56 60 2980 2984 O
1 61 62 2985 2986 B-upper_bound
cm 63 65 2987 2989 I-upper_bound
in 66 68 2990 2992 I-upper_bound
diameter 69 77 2993 3001 I-upper_bound
and 78 81 3002 3005 O
asymptomatic 82 94 3006 3018 O
are 95 98 3019 3022 O
eligible 99 107 3023 3031 O

Platelet 0 8 3032 3040 B-clinical_variable
count 9 14 3041 3046 I-clinical_variable
greater 15 22 3047 3054 O
than 23 27 3055 3059 O
or 28 30 3060 3062 O
equal 31 36 3063 3068 O
to 37 39 3069 3071 O
100,000 40 47 3072 3079 B-lower_bound
/ 47 48 3079 3080 I-lower_bound
mm^3 48 52 3080 3084 I-lower_bound

Serology 0 8 3085 3093 B-treatment

Seronegative 0 12 3094 3106 O
for 13 16 3107 3110 O
HIV 17 20 3111 3114 B-chronic_disease
antibody 21 29 3115 3123 O
. 29 30 3123 3124 O
( 31 32 3125 3126 O
The 32 35 3126 3129 O
experimental 36 48 3130 3142 O
treatment 49 58 3143 3152 B-treatment
being 59 64 3153 3158 O
evaluated 65 74 3159 3168 O
in 75 77 3169 3171 O
this 78 82 3172 3176 O
protocol 83 91 3177 3185 O
depends 92 99 3186 3193 O
on 100 102 3194 3196 O
an 103 105 3197 3199 O
intact 106 112 3200 3206 O
immune 113 119 3207 3213 O
system 120 126 3214 3220 O
. 126 127 3220 3221 O
Patients 128 136 3222 3230 O
who 137 140 3231 3234 O
are 141 144 3235 3238 O
HIV 145 148 3239 3242 O
seropositive 149 161 3243 3255 O
can 162 165 3256 3259 O
have 166 170 3260 3264 O
decreased 171 180 3265 3274 O
immune 181 187 3275 3281 O
- 187 188 3281 3282 O
competence 188 198 3282 3292 O
and 199 202 3293 3296 O
thus 203 207 3297 3301 O
be 208 210 3302 3304 O
less 211 215 3305 3309 O
responsive 216 226 3310 3320 O
to 227 229 3321 3323 O
the 230 233 3324 3327 O
experimental 234 246 3328 3340 O
treatment 247 256 3341 3350 O
and 257 260 3351 3354 O
more 261 265 3355 3359 O
susceptible 266 277 3360 3371 O
to 278 280 3372 3374 O
its 281 284 3375 3378 O
toxicities 285 295 3379 3389 O
. 295 296 3389 3390 O
) 296 297 3390 3391 O

Seronegative 0 12 3392 3404 O
for 13 16 3405 3408 O
hepatitis 17 26 3409 3418 B-chronic_disease
B 27 28 3419 3420 I-chronic_disease
antigen 29 36 3421 3428 O
, 36 37 3428 3429 O
and 38 41 3430 3433 O
seronegative 42 54 3434 3446 O
for 55 58 3447 3450 O
hepatitis 59 68 3451 3460 B-chronic_disease
C 69 70 3461 3462 I-chronic_disease
antibody 71 79 3463 3471 O

Serum 0 5 3472 3477 B-clinical_variable
ALT 6 9 3478 3481 I-clinical_variable
/ 9 10 3481 3482 I-clinical_variable
AST 10 13 3482 3485 I-clinical_variable
less 14 18 3486 3490 O
than 19 23 3491 3495 O
or 24 26 3496 3498 O
equal 27 32 3499 3504 O
to 33 35 3505 3507 O
2.5 36 39 3508 3511 B-upper_bound
times 40 45 3512 3517 I-upper_bound
the 46 49 3518 3521 I-upper_bound
upper 50 55 3522 3527 I-upper_bound
limit 56 61 3528 3533 I-upper_bound
of 62 64 3534 3536 I-upper_bound
normal 65 71 3537 3543 I-upper_bound

Serum 0 5 3544 3549 B-clinical_variable
creatinine 6 16 3550 3560 I-clinical_variable
less 17 21 3561 3565 O
than 22 26 3566 3570 O
or 27 29 3571 3573 O
equal 30 35 3574 3579 O
to 36 38 3580 3582 O
1.6 39 42 3583 3586 B-upper_bound
mg 43 45 3587 3589 I-upper_bound
/ 45 46 3589 3590 I-upper_bound
dl 46 48 3590 3592 I-upper_bound

Subjects 0 8 3593 3601 O
must 9 13 3602 3606 O
be 14 16 3607 3609 O
co 17 19 3610 3612 B-treatment
- 19 20 3612 3613 I-treatment
enrolled 20 28 3613 3621 I-treatment
in 29 31 3622 3624 I-treatment
protocol 32 40 3625 3633 I-treatment
03 41 43 3634 3636 I-treatment
- 43 44 3636 3637 I-treatment
C-0277 44 50 3637 3643 I-treatment

Symptoms 0 8 3644 3652 O
of 9 11 3653 3655 O
respiratory 12 23 3656 3667 B-chronic_disease
dysfunction 24 35 3668 3679 I-chronic_disease

Total 0 5 3680 3685 B-clinical_variable
bilirubin 6 15 3686 3695 I-clinical_variable
less 16 20 3696 3700 O
than 21 25 3701 3705 O
or 26 28 3706 3708 O
equal 29 34 3709 3714 O
to 35 37 3715 3717 O
1.5 38 41 3718 3721 B-upper_bound
mg 42 44 3722 3724 I-upper_bound
/ 44 45 3724 3725 I-upper_bound
dl 45 47 3725 3727 I-upper_bound
, 47 48 3727 3728 O
except 49 55 3729 3735 O
in 56 58 3736 3738 O
patients 59 67 3739 3747 O
with 68 72 3748 3752 O
Gilbert 73 80 3753 3760 B-chronic_disease
s 81 82 3761 3762 I-chronic_disease
Syndrome 83 91 3763 3771 I-chronic_disease
who 92 95 3772 3775 O
must 96 100 3776 3780 O
have 101 105 3781 3785 O
a 106 107 3786 3787 O
total 108 113 3788 3793 B-clinical_variable
bilirubin 114 123 3794 3803 I-clinical_variable
less 124 128 3804 3808 O
than 129 133 3809 3813 O
3.0 134 137 3814 3817 B-upper_bound
mg 138 140 3818 3820 I-upper_bound
/ 140 141 3820 3821 I-upper_bound
dl 141 143 3821 3823 I-upper_bound

WBC 0 3 3824 3827 B-clinical_variable
greater 4 11 3828 3835 O
than 12 16 3836 3840 O
or 17 19 3841 3843 O
equal 20 25 3844 3849 O
to 26 28 3850 3852 O
3000 29 33 3853 3857 B-lower_bound
/ 33 34 3857 3858 I-lower_bound
mm^3 34 38 3858 3862 I-lower_bound

Women 0 5 3863 3868 B-gender
of 6 8 3869 3871 O
child 9 14 3872 3877 O
- 14 15 3877 3878 O
bearing 15 22 3878 3885 O
potential 23 32 3886 3895 O
must 33 37 3896 3900 O
have 38 42 3901 3905 O
a 43 44 3906 3907 O
negative 45 53 3908 3916 B-pregnancy
pregnancy 54 63 3917 3926 I-pregnancy
test 64 68 3927 3931 O
because 69 76 3932 3939 O
of 77 79 3940 3942 O
the 80 83 3943 3946 O
potentially 84 95 3947 3958 O
dangerous 96 105 3959 3968 O
effects 106 113 3969 3976 O
of 114 116 3977 3979 O
the 117 120 3980 3983 O
treatment 121 130 3984 3993 B-treatment
on 131 133 3994 3996 O
the 134 137 3997 4000 O
fetus 138 143 4001 4006 O

Women 0 5 4007 4012 B-gender
of 6 8 4013 4015 O
child 9 14 4016 4021 O
- 14 15 4021 4022 O
bearing 15 22 4022 4029 O
potential 23 32 4030 4039 O
who 33 36 4040 4043 O
are 37 40 4044 4047 B-pregnancy
pregnant 41 49 4048 4056 I-pregnancy
or 50 52 4057 4059 O
breastfeeding 53 66 4060 4073 O
because 67 74 4074 4081 O
of 75 77 4082 4084 O
the 78 81 4085 4088 O
potentially 82 93 4089 4100 O
dangerous 94 103 4101 4110 O
effects 104 111 4111 4118 O
of 112 114 4119 4121 O
the 115 118 4122 4125 O
treatment 119 128 4126 4135 B-treatment
on 129 131 4136 4138 O
the 132 135 4139 4142 O
fetus 136 141 4143 4148 O
or 142 144 4149 4151 O
infant 145 151 4152 4158 O

by 0 2 4159 4161 O
immunohistochemistry 3 23 4162 4182 B-treatment
of 24 26 4183 4185 O
resected 27 35 4186 4194 O
tissue 36 42 4195 4201 O
defined 43 50 4202 4209 O
as 51 53 4210 4212 O
10 54 56 4213 4215 B-lower_bound
% 56 57 4215 4216 I-lower_bound
or 58 60 4217 4219 O
greater 61 68 4220 4227 O
of 69 71 4228 4230 O
tumor 72 77 4231 4236 B-cancer
cells 78 83 4237 4242 I-cancer
being 84 89 4243 4248 O
2 90 91 4249 4250 B-lower_bound
- 91 92 4250 4251 O
3 92 93 4251 4252 B-upper_bound
+ 93 94 4252 4253 I-upper_bound
for 95 98 4254 4257 O
MAGE 99 103 4258 4262 B-clinical_variable
- 103 104 4262 4263 I-clinical_variable
A3 104 106 4263 4265 I-clinical_variable
, 106 107 4265 4266 O
or 108 110 4267 4269 O
serum 111 116 4270 4275 O
antibody 117 125 4276 4284 O
reactive 126 134 4285 4293 O
with 135 139 4294 4298 O
MAGE 140 144 4299 4303 O
- 144 145 4303 4304 O
A3 145 147 4304 4306 O

greater 0 7 4307 4314 O
than 8 12 4315 4319 O
or 13 15 4320 4322 O
equal 16 21 4323 4328 O
to 22 24 4329 4331 O
65 25 27 4332 4334 B-lower_bound
years 28 33 4335 4340 I-lower_bound
old 34 37 4341 4344 O

